Results 91 to 100 of about 3,023 (195)

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. [PDF]

Int J Chron Obstruct Pulmon Dis, 2023
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS.   +12 more
europepmc   +1 more source

Therapeutic Effect Observation of Tiotropium Bromide in the Treatment of Overlap Syndrome

, 2020
Objective: To study the M receptor blocker on inhalation in patients with overlap syndrome (chronic obstructive pulmonary disease and Obstructive sleep apnea syndrome) curative effect analysis.
Wang, Ting, Huang, Yunchao
core  

1H-NMR-based metabolic profiling of healthy individuals and high-resolution CT-classified phenotypes of COPD with treatment of tiotropium bromide

International Journal of COPD, 2018
Li-Chuan Tan,1 Wen-Jie Yang,2 Wei-Ping Fu,1 Ping Su,2 Jing-Kui Shu,1 Lu-Ming Dai1 1Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, People’s Republic of China ...
Tan LC, Yang WJ, Fu WP, Su P, Shu JK, Dai LM   +5 more
doaj  

Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. [PDF]

J Manag Care Spec Pharm, 2023
Sethi S, Palli SR, Bengtson LGS, Buysman EK, Clark B, Sargent A, Shaikh A, Ferguson GT.   +7 more
europepmc   +1 more source

Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation

, 2011
Background: a secondary pre-specified analysis of the UPLIFT cohort demonstrated that the inclusion of tiotropium bromide in the routine care of GOLD stage II (moderate) chronic obstructive pulmonary disease (COPD) patients is associated with stronger ...
Iannazzo, Sergio, Zaniolo, Orietta, Carsi, Michela   +2 more
core   +1 more source

Tiotropium in asthma: Back to the future of anticholinergic treatment [PDF]

, 2017
Asthma is among the most common chronic diseases worldwide; however, despite progresses in the understanding of the patho-physiological mechanisms and advances in the development of new therapeutic options and strategies, the disease remains uncontrolled
Scichilone N, Bonini M, Scichilone, Nicola, Bonini, Matteo, Nicola Scichilone, Matteo Bonini   +5 more
core   +1 more source

Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease. [PDF]

Comput Math Methods Med, 2021
Yu S, Zhang C, Yan Z, Fang Q, Gao X.
europepmc   +1 more source

The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide

, 2014
This study characterised the in vitro and in vivo profiles of two novel long-acting muscarinic antagonists, aclidinium bromide and glycopyrronium bromide, using tiotropium bromide and ipratropium bromide as comparators.
Ramos, Israel, Otal, Raquel, Beleta, Jorge, Alberti, Joan, Miralpeix, Montserrat, Sentellas, Sonia, Aparici, Monica, Vilella, Dolors, Carcasona, Carla, Montero, José Luis, Calama, Elena, Gavaldà, Amadeu   +11 more
core   +1 more source

Efficacy of tiotropium in the prevention of exacerbations of COPD

Therapeutic Advances in Respiratory Disease, 2009
Exacerbations are the most frequent cause of medical visits, hospital admissions and death among patients with chronic obstructive pulmonary disease (COPD).
Antonio Anzueto, Marc Miravitlles
doaj   +1 more source

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History. [PDF]

Int J Chron Obstruct Pulmon Dis, 2023
Sethi S, Clark B, Bengtson LGS, Buysman EK, Palli S, Sargent A, Shaikh A, Ferguson GT.   +7 more
europepmc   +1 more source